NCT03431116 is a clinical trial of ultrasound in Placenta Previa, sponsored by Assiut University.

Who is sponsoring NCT03431116?

NCT03431116 is sponsored by Assiut University.

What drugs are being tested in NCT03431116?

Interventions in NCT03431116: ultrasound.

What condition does NCT03431116 study?

NCT03431116 studies Placenta Previa.

Is NCT03431116 still recruiting?

NCT03431116 is currently completed. Last updated 13 February 2018.

Last reviewed 2018-02-13 · How we verify

NCT03431116

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Low Implanted Second Trimester Placenta and Placenta Previa

Completed Last updated 13 February 2018

What this trial tests

trial testing ultrasound in Placenta Previa in 52 participants. Completed in 30 April 2017.

Timeline

1 October 2016

Primary endpoint
30 March 2017

30 April 2017

Quick facts

Lead sponsor	Assiut University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	52
Start date	1 October 2016
Primary completion	30 March 2017
Estimated completion	30 April 2017
Sites	1 location across Egypt

Drugs / interventions tested

ultrasound

Conditions studied

Placenta Previa — all drugs for Placenta Previa →

Sponsor

Assiut University

Who can join

Adults 20 to 45, female only, with Placenta Previa. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Placenta Previa is defined as a placenta implanted in the lower segment of the uterus, presenting ahead of the leading pole of the fetus (over or near the internal os). The prevalence of placenta previa has been estimated to be approximately 0.5% of all pregnancies, and this increase correlates to the elevated cesarean section rate . In Egypt, the prevalence of placenta previa is around 1.3% in Sohag Governorate and 1.5% in Aswan region according to. Although various studies have tried to address risk factors associated with Placenta Previa development, the etiology of placenta previa still remains obscure. Several risk actors have been identified as strong contributors to placenta previa development. It is also a significant contributor to severe postpartum hemorrhage.Risk factors include; history of previous cesarean section, advanced maternal age, history of previous abortions, high parity and substance abuse during pregnancy (cigarette smoking), placental size (multiple pregnancy), endometrial damage (previous dilatation and curettage), uterine scars and pathology (previous myomectomy or endometritis), placental pathology (marginal cord insertions and succenturiate lobes), previous placental Previa, and curiously.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of ultrasound

Trials testing the same drug.

NCT07473908 — Ultrasound Assessment of Achilles Tendon-Neurovascular Distance in Infants With Unilateral Clubfoot · not yet recruiting
NCT07408596 — "Ultrasound Measures and Clinical Outcomes in Healthy Individuals, Mild and Moderate Carpal Tunnel Syndrome Patients" · completed
NCT06901063 — Research of Brachial Plexus Anatomy · completed
NCT07351292 — Ultrasound or Whole Body Vibration on Knee Motion and Function in CP · NA · completed
NCT06576128 — Ultrasound-Guided Transversus Abdominis Plan (TAP) Block in Endovascular Cardiac Interventions · NA · recruiting

Other recruiting trials for Placenta Previa

Currently open trials in the same condition.

NCT07025954 — Planned Delivery at 37 Versus 36 Weeks in Pregnancies With Placenta Previaand Accreta · NA · recruiting
NCT06849349 — EXAMINATION OF SOME MOLECULES IN PLACENTAS OF PATIENTS WITH PLACENTA PREVIA, PLACENTA PERCREATA · recruiting
NCT06867874 — Syncytiotrophoblast-derived Extracellular Vesicles in Placenta Previa and Accreta Spectrum · NA · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03431116 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 13 February 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03431116.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing